Effect of short-term topical corticosteroid treatment on mucosal enzyme systems in patients with distal inflammatory bowel disease

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1539-1545

  Scheurlen, Christian ^a   Allgayer, Hubert ^b   Hardt, Manfred ^c   Kruis, Wolfgang ^c  

^a UNIVERSITY OF BONN   (Germany)

^b Medical Department   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Hydrocortisone acetate; Inflammatory bowel disease, therapy; Mucosal function; Topical corticosteroids

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CORTICOSTEROID; DIPHENYLAMINE; DNA; GLUCOCORTICOID; HYDROCORTISONE ACETATE; OUABAIN;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DIARRHEA; DOUBLE BLIND PROCEDURE; ENDOSCOPY; ENTERITIS; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; SIGMOIDOSCOPY; ULCERATIVE COLITIS;

5'-NUCLEOTIDASE; ADMINISTRATION, RECTAL; ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS; DNA; FEMALE; HUMANS; HYDROCORTISONE; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NA(+)-K(+)-EXCHANGING ATPASE; PROSPECTIVE STUDIES;

EID: 0031736585     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hawthorne AB, Hawkey CJ: Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy. Drugs 1989; 38:267-288.
2. Lamers CBHW: Future of topical steroid enemas. Eur J Gastroenterol Hepatol 1994; 6:121-123.
3. Sandle GJ, McGlove F: Mechanism of acute stimulation of colonic Na and K transport by glucocorticoid hormones. Gut 1986; 27:A593.
4. Sandle GJ, Binder HJ: Corticosteroids and intestinal ion transport. Gastroenterology 1987; 93:188-196.
5. Hawker PC, McKay JS, Turnberg LA: Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease. Gastroenterology 1980; 79:508-511.
6. Sandle GJ, Hayslett JP, Binder HJ: The effect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitis. Gut 1986; 27:309-316.
7. +)-ATPase and adenylate cyclase activities in children with toddler diarrhea and the postenteritis syndrome. Pediatr Res 1980; 14:1382-1386.
8. +)-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease. Dig Dis Sci 1988; 33:417-422.
9. McChung HJ, Butler DG, Kerzner B, Gall DG, Hamilton JR: Transmissible gastroenteritis. Mucosal ion transport in acute viral enteritis. Gastroenterology 1976; 70:1091-1095.
10. Byrd JC, Fearney FJ, Kim YS: Rat intestinal nucleotide sugar pyrophosphatase. Localization, partial purification, and substrate specifity. J Biol Chem 1985; 260:7474-7480.
11. +)-stimulated ATPase activity in rat intestinal mucosa. Biochim Biophys Acta 1969; 173:456-468.
12. Truelove SC, Witts LJ: Cortisone in ulcerative colitis. Brit Med J 1955; 2:1041-1048.
13. Best WR, Becktel JM, Singleton JW, Kern F: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study (NCCDS). Gastroenterology 1976; 70:439-444.
14. Gomes P, du Boulay C, Smith CL, Holdstock G: Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986; 27:92-95.
15. Holmquist L, Ahren C, Fallstrom SP: Relationship between results of laboratory tests and inflammatory activity assessed by colonoscopy in children and adolescents with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 1989; 9:187-193.
16. Binder V: A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol 1970; 5:627-632.
17. +)-activated ATPase from ox brain. Europ J Biochem 1967; 1:334-343.
18. +)-ATPase by arachidonic and linoleic acid. Naunyn-Schmiedeberg's Arch Pharmacol 1986; 332:398-402.
19. Solyom A, Trams EG: Enzyme markers in characterization of isolated plasma membranes. Enzyme 1972; 13:329-372.
20. Chen PS, Toribara TY, Warner H: Microdetermination of phosphorus. Anal Chem 1956; 28:1756-1758.
21. Burton K: A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem 1956; 62:315-323.
22. Lowry OH, Rosebrough HJ, Farr AC, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 93:265-275.
23. STATISTICA™ software package for the Windows™ operating system: StatSoft™ Inc., Tulsa/USA, 1994.
24. Charkraborthy TK, Bhatia D, Heading RC, Ford MJ: Salicylate induced exacerbation of ulcerative colitis. Gut 1987; 28:613-615.
25. +-ATPase activity. Isr J Med Sci 1984; 20:677-680.
26. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE: Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Int Med 1993; 119:1198-1208.
27. +-activated adenosine triphosphatase and intestinal elctrolyte transport. J Clin Invest 1975; 56:653-660.
28. Black HE: The effects of steroids upon the gastrointestinal tract. Toxicol Pathol 1988; 16:213-222.
29. Pressley L, Funder JW: Glucocorticoid and mineralocorticoid receptors in gut mucosa. Endocrinology 1975; 97:588-596.
30. McAlindon ME, Mahida YR: Pro-inflammatory cytokines in inflammatory bowel disease. Aliment Pharmacol Ther 1996; 10 (Suppl. 2):72-74.
31. Zimmermann MJ, Jewell DP: Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treament of ulcerative colitis and Crohn's disease. Aliment Pharmacol Ther 1996; 10 (Suppl. 2):93-98.
32. Porro GB, Prantera C, Campieri M, Petrillo M, Campanini MC, Gionchetti P, et al: Comparative trial of methylprednisolone and budesonide enemas in active distal ulcerative colitis. Eur J Gastroenterol Hepatol 1994; 6:125-130.
33. Thomsen OO, Andersen T, Langholz E, Lofberg R, Malchow-Moller A, Matzen P, et al: Lack of adrenal gland suppression with budesonide enema in active distal ulcerative colitis: a prednisolone-controlled 8-week study. Eur J Gastroenterol Hepatol 1994; 6:507-511.
34. Lindmark B: Short- and long-term steroid side effects: The importance for patients with inflammatory bowel disease. Res Clin Forums 1993; 15:35-40.
35. Pena AS: A comparative review of available rectal steroids in the treatment of distal disease. Res Clin Forums 1993; 15:57-64.
36. Sachar DB: Budesonide for inflammatory bowel disease-is it a magic bullet? New Engl J Med 1994; 331:873-874.
37. +-ATPase. In: Methods in enzymology. Vol. 156, Chapt. 19. Academic Press. New York 1988; pp. 201-213.
38. Mollmann H, Barth J, Mollmann C, Tunn S, Krieg M, Derendorf H: Pharmacokinetics and rectal bioavailability of hydrocortisone acetate. J Pharmaceut Sci 1991; 80:835-836.
39. Farthing MJG, Ruthland MD, Clark ML: Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis. Brit Med J 1979; 2:822-824.
40. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 1984; 87:1344-1350.
41. Bos A, Wever R, Roos D: Characterization and quantification of the peroxidase in human monocytes. Biochim Biophys Acta 1978; 525:37-44.